Learn more about the use of mHealth technology in mental health care
In this video, Monsenso user Mads Trier-Blom speaks of his experience using the Monsenso app as a part of a clinical trial. The Monsenso app helped him to become more aware of his mood, and other factors, such as sleep, and their influence on his bipolar affective disorder.
Swedish Psychiatrist Kristoffer Södersten shares his experience using the Monsenso clinic to help treat his clients, and talks about how mobile health has helped him improve delivering psychiatric treatment.
The U.S Healthcare Information and Management Systems Society (HiMSS) released a report titled “Leveraging mobile technology to reduce hospital readmissions.” According to the Centres for Medicare and Medicaid Services (CMS), Medicare has been overwhelmed with...
Monsenso provides medication adherence and behavioural monitoring components in H2020 Funded R-LiNK Study
Monsenso is participating in R-LiNK, the major new study for developing a more complete understanding of the reactions and effects of taking lithium. Monsenso is now involved in more than ten pan European and domestic research projects in the mental health & affective disorders field.
Electronic and interactive monitoring systems can improve communication between clinicians and patients during the psychiatric medication switching process.
mHealth provides the opportunity to offer scalable and cost-effective mental healthcare. One of the greatest challenges the healthcare systems face is the long-term care of individuals with severe mental disorders. Fortunately, some of these issues can be partially solved with the use of mHealth technology.
Pharma can benefit from mHealth solutions by using them in clinical trials and by offering them to HCPs as part of a comprehensive treatment solution.
According to a new report by a research firm in Sweden, there were 7.1 million patients monitored remotely worldwide in 2016, which is an increase of 44%. The report also forecasts that the number will grow to 50.2 million by 2021.
Using mHealth solutions for clinical trials as data-collection tools, can potentially revolutionise clinical research. Wearable devices and mobile health solutions can offer pharmaceutical companies access to additional patient data to provide a more comprehensive overview of safety and efficacy.
According to an article published on Harvard Business Review, digital health tools have the potential to provide effective, low-cost ways to prevent and treat chronic illnesses. The article states that these technology-based solutions that have a clinical impact on disease comparable to that of a drug, and they use consumer-grade technology such as mobile devices and big data analytics that can be deployed in real-time and at scale, which is critical for the management of chronic diseases.